The X protein of hepatitis B virus coactivates potent activation domains.

AUTOR(ES)

Haviv, I

RESUMO

Transactivation by hepatitis B virus X protein (pX) is promiscuous, but it requires cellular activators. To study the mode of action of pX, we coexpressed pX with Gal4-derived activators in a cotransfection system. Twelve different activators bearing different types of activation domains were compared for their response to pX. Because pX indirectly increases the amount of the activators, tools were developed to compare samples with equivalent amount of activators. We demonstrate that pX preferentially coactivates potent activators, especially those with acidic activation domains. Weak activators with nonacidic activation domains are not potentiated by pX. Interestingly, Gal4E1a, which is not rich in acidic residues but interacts with similar molecular targets, also responds to pX. The response to pX correlated with the strength of the activation domain. Collectively, these data imply that pX is a coactivator, which offers a molecular basis for the pleiotropic effects of pX on transcription.

Documentos Relacionados

• Identification of protein-binding sites in the hepatitis B virus enhancer and core promoter domains.
• trans-activation of viral enhancers by the hepatitis B virus X protein.
• Visna virus Tat protein: a potent transcription factor with both activator and suppressor domains.
• Trans-activation of the human immunodeficiency virus long terminal repeat by the hepatitis B virus X protein.
• Mapping of B-cell epitopes of the human hepatitis B virus X protein.